SERB SA

Company number 0538.813.719

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 4
Amount won alone: €1,164,970 excl. VAT
Shared contracts: 2 (multi-supplier framework agreements)
Period: 27 October 2025 – 9 October 2026

Its main clients

Ekstremalių sveikatai situacijų centras prie SAM · 1 contract
Pohjois-Pohjanmaan hyvinvointialue · 1 contract
DAK-Gesundheit · 1 contract
FOD Binnenlandse Zaken · 1 contract

Where and what

Supplies · 4

East Flanders · 1

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
1 September 2027 re-tender around March 2027	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate) DAK-Gesundheit	Abacus Medicine A/S axunio Pharma GmbH Hormosan Pharma GmbH SERB SA 6 bids received	€1
1 January 2028 re-tender around July 2027	Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027 Pohjois-Pohjanmaan hyvinvointialue	medac Gesellschaft für klinische Spezialpräparate G.m.b.H, sivuliike Suomessa Ailon Pharma Oy Abacus Medicine A/S ALK-Abéllo Nordic A/S AOP Orphan Pharmaceuticals Sweden AB AbbVie Oy Abboxia AB Abcur AB Abena Finland OY Accord Healthcare Oy Aguettant Nordic ApS Alexion Pharma Nordics AB Aspen Pharma Ireland Limited Astellas Pharma a/s AstraZeneca Oy Avansor Pharma Oy Avia Pharma Oy B. Braun Medical Oy Bausch & Lomb Nordic AB Baxter Oy Bayer Oy Amgen Aktiebolag, filial i Finland Berlin-Chemie/A. Menarini Suomi Oy Berner Oy betapharm Arzneimittel GmbH 2care4 Aps, filial BioGaia Finland Oy Biocodex Oy Bioglan AB Boehringer Ingelheim Finland Ky Bracco Imaging Scandinavia AB Biogen Finland Oy CNX Therapeutics Ltd CSL Behring AB CampusPharma AB Camurus AB Celltrion Healthcare Finland Oy Chiesi Pharma AB Danone Oy Desitin Pharma Oy EQL Pharma AB Eisai AB Essential Pharma Limited Evolan 161 bids received	€142

Contracts won

Date	Contract	Buyer	Amount
09/10/2026	Hidroksikobalaminas	Ekstremalių sveikatai situacijų centras prie SAM	€450,000
08/09/2026	Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027	Pohjois-Pohjanmaan hyvinvointialue	€142 shared by 142
08/07/2026	Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)	DAK-Gesundheit	€1 shared by 4
27/10/2025	Levering (fabricage en levering) van 10 miljoen jodiumtabletten	FOD Binnenlandse Zaken	€714,970

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.